HEMO Invest ApS: Financial statements 2022
CVR: 38403125
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HEMO Invest ApS (CVR 38403125) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -29,114 and a net result of DKK -3,069,301 compared with DKK 17,176,670 the year before. Equity in the 2022 report amounted to DKK 27,610,916. The solvency ratio was 100%.
- Gross Profit
- DKK -29,114
- Profit/Loss
- DKK -3,069,301
- Equity
- DKK 27,610,916
- Total Assets
- DKK 27,617,167
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -29K | -3.1M | 27.6M | - |
| 2021 | - | -55K | 17.2M | 30.8M | - |
| 2020 | - | -43K | 8.9M | 13.7M | - |
| 2019 | - | -18K | 1.1M | 5M | - |
| 2018 | - | -17K | 1.6M | 4M | - |
Official annual report
Keep an eye on HEMO Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HEMO Invest ApS has published its annual report for 2021. Gross profit came to DKK -54,650, and the net result was DKK 17,176,670.
About HEMO Invest ApS
HEMO Invest ApS is a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Mortensen. The company is owned by Henrik Mortensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046.
